OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review
Aitor Odriozola, Álvaro Santos‐Laso, María Del Barrio, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7791-7791
Open Access | Times Cited: 18
Aitor Odriozola, Álvaro Santos‐Laso, María Del Barrio, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7791-7791
Open Access | Times Cited: 18
Showing 18 citing articles:
What Is New in Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals: From Bench to Bedside
Pojsakorn Danpanichkul, Kanokphong Suparan, Donghee Kim, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 1, pp. 278-278
Open Access | Times Cited: 21
Pojsakorn Danpanichkul, Kanokphong Suparan, Donghee Kim, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 1, pp. 278-278
Open Access | Times Cited: 21
Elevated levels of alcohol dehydrogenase aggravate ethanol-evoked cardiac remodeling and contractile anomalies through FKBP5-yap-mediated regulation of ferroptosis and ER stress
Lu Qi, Xing Qin, Chu Chen, et al.
Life Sciences (2024) Vol. 343, pp. 122508-122508
Closed Access | Times Cited: 15
Lu Qi, Xing Qin, Chu Chen, et al.
Life Sciences (2024) Vol. 343, pp. 122508-122508
Closed Access | Times Cited: 15
Different minimal alcohol consumption in male and female individuals with metabolic dysfunction‐associated fatty liver disease
Yixuan Zhu, Xiaoming Xu, Zhiwen Fan, et al.
Liver International (2024) Vol. 44, Iss. 3, pp. 865-875
Open Access | Times Cited: 2
Yixuan Zhu, Xiaoming Xu, Zhiwen Fan, et al.
Liver International (2024) Vol. 44, Iss. 3, pp. 865-875
Open Access | Times Cited: 2
Genetically predicted fatty liver disease and risk of psychiatric disorders: A mendelian randomization study
XU Wei-ming, Hai-Fu Zhang, Yong-Hang Feng, et al.
World Journal of Clinical Cases (2024) Vol. 12, Iss. 14, pp. 2359-2369
Open Access | Times Cited: 2
XU Wei-ming, Hai-Fu Zhang, Yong-Hang Feng, et al.
World Journal of Clinical Cases (2024) Vol. 12, Iss. 14, pp. 2359-2369
Open Access | Times Cited: 2
A Machine Learning-Based Method for Detecting Liver Fibrosis
Miguel Suárez, Raquel Martínez, Ana María Torres, et al.
Diagnostics (2023) Vol. 13, Iss. 18, pp. 2952-2952
Open Access | Times Cited: 5
Miguel Suárez, Raquel Martínez, Ana María Torres, et al.
Diagnostics (2023) Vol. 13, Iss. 18, pp. 2952-2952
Open Access | Times Cited: 5
Profiling the organ membrane proteome dysregulation in the context of liver disease
Frank Antony, Zora Brough, Mona Orangi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Frank Antony, Zora Brough, Mona Orangi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Pathways from insulin resistance to incident cardiovascular disease: a Bayesian network analysis
Xue Tian, Shuohua Chen, Xue Xia, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Xue Tian, Shuohua Chen, Xue Xia, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Evaluation of metabolic dysfunction-associated steatotic liver disease (MASLD) terminology in different clinical settings
Paula Iruzubieta, Álvaro Santos‐Laso, M. Arias, et al.
Journal of Hepatology (2023) Vol. 80, Iss. 3, pp. e121-e123
Open Access | Times Cited: 4
Paula Iruzubieta, Álvaro Santos‐Laso, M. Arias, et al.
Journal of Hepatology (2023) Vol. 80, Iss. 3, pp. e121-e123
Open Access | Times Cited: 4
Linking Metallic Micronutrients and Toxic Xenobiotics to Atherosclerosis and Fatty Liver Disease—Postmortem ICP-MS Analysis of Selected Human Tissues
Jacek Baj, Beata Kowalska, Aleksandra Barbachowska, et al.
Nutrients (2023) Vol. 15, Iss. 15, pp. 3458-3458
Open Access | Times Cited: 3
Jacek Baj, Beata Kowalska, Aleksandra Barbachowska, et al.
Nutrients (2023) Vol. 15, Iss. 15, pp. 3458-3458
Open Access | Times Cited: 3
Profiling the organ membrane proteome dysregulation in the context of liver disease
Frank Antony, Zora Brough, Mona Orangi, et al.
Authorea (Authorea) (2024)
Open Access
Frank Antony, Zora Brough, Mona Orangi, et al.
Authorea (Authorea) (2024)
Open Access
Hepatoprotective effects of diosmin: a narrative review
Emad H.M. Hassanein, Hanan S. Althagafy, Mohamed Baraka, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Open Access
Emad H.M. Hassanein, Hanan S. Althagafy, Mohamed Baraka, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Open Access
Enfermedad hepática relacionada con el alcohol
Joaquín Cabezas, Antonio Cuadrado, Jorge Cea Rodríguez, et al.
Medicine - Programa de Formación Médica Continuada Acreditado (2024) Vol. 14, Iss. 6, pp. 294-304
Closed Access
Joaquín Cabezas, Antonio Cuadrado, Jorge Cea Rodríguez, et al.
Medicine - Programa de Formación Médica Continuada Acreditado (2024) Vol. 14, Iss. 6, pp. 294-304
Closed Access
Sensitive Profiling of Mouse Liver Membrane Proteome Dysregulation Following a High‐Fat and Alcohol Diet Treatment
Frank Antony, Zora Brough, Mona Orangi, et al.
PROTEOMICS (2024)
Open Access
Frank Antony, Zora Brough, Mona Orangi, et al.
PROTEOMICS (2024)
Open Access
Enhancing global hepatocellular carcinoma management: Bridging Eastern and Western perspectives on dexamethasone and N-acetylcysteine before transarterial chemoembolization
Thang Viet Luong, Ninh T. Nguyen, Le Bodic L, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 47, pp. 4983-4990
Closed Access
Thang Viet Luong, Ninh T. Nguyen, Le Bodic L, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 47, pp. 4983-4990
Closed Access
Exploring the gut microbiome: A potential biomarker for cancer diagnosis, prognosis, and therapy
Eui-Jeong Han, Ji‐Seon Ahn, Yu-Jin Choi, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189251-189251
Closed Access
Eui-Jeong Han, Ji‐Seon Ahn, Yu-Jin Choi, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189251-189251
Closed Access
Alcohol Use Disorder and Alcohol-Associated Liver Disease: New Definitions, Screening, and Treatment.
Giovanni A. Roldan, Christopher Tricarico, Robert S. Brown
PubMed (2024) Vol. 20, Iss. 11, pp. 662-671
Closed Access
Giovanni A. Roldan, Christopher Tricarico, Robert S. Brown
PubMed (2024) Vol. 20, Iss. 11, pp. 662-671
Closed Access
Statins for treatment of fatty liver disease: Recent advances
Xiaohui Fang, Caie Wang, Jiao Deng, et al.
Shijie huaren xiaohua zazhi (2023) Vol. 31, Iss. 16, pp. 659-665
Open Access | Times Cited: 1
Xiaohui Fang, Caie Wang, Jiao Deng, et al.
Shijie huaren xiaohua zazhi (2023) Vol. 31, Iss. 16, pp. 659-665
Open Access | Times Cited: 1
Atherogenic features of the fatty acid profile of erythrocyte membranes of patients with fatty liver disease of mixed genesis
М. В. Кручинина, А. В. Белковец, М. В. Паруликова, et al.
Ateroscleroz (2023) Vol. 19, Iss. 4, pp. 350-368
Open Access
М. В. Кручинина, А. В. Белковец, М. В. Паруликова, et al.
Ateroscleroz (2023) Vol. 19, Iss. 4, pp. 350-368
Open Access
